ScholarLens Back to search
2011•Экспериментальная и клиническая гастроэнтерологияRequires access

Динамика сывороточных il-17а, il-17f и IL-23 у больных воспалительными заболеваниями кишечника

Л. Б. Лазебник, В. Э. Сагынбаева, О. В. Князев, И Н Ручкина, Ljupcho Efremov

Open publisher page 0 citations

Abstract

The analysis of the levels of proinflammatory cytokines IL-17A, IL-17F and IL-23 allow to evaluate the effectiveness of the therapy:, so MSCs systemic immunosuppressive therapy and corticosteroids increasingly reduces the level of all studied proinflammatory cytokines, while in therapy with infliximab, a selective immunosuppressive agent, significantly less effect on the level of proinflammatory cytokines IL-17A, IL-17F and IL-23.

About this research paper

What this paper is about

The analysis of the levels of proinflammatory cytokines IL-17A, IL-17F and IL-23 allow to evaluate the effectiveness of the therapy:, so MSCs systemic immunosuppressive therapy and corticosteroids increasingly reduces the level of all studied proinflammatory cytokines, while in therapy with infliximab, a selective immunosuppressive agent, significantly less effect on the level of proinflammatory cytokines IL-17A, IL-17F and IL-23.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The analysis of the levels of proinflammatory cytokines IL-17A, IL-17F and IL-23 allow to evaluate the effectiveness of the therapy:, so MSCs systemic immunosuppressive therapy and corticosteroids increasingly reduces the level of all studied proinflammatory cytokines, while in therapy with infliximab, a selective immunosuppressive agent, significantly less effect on the level of proinflammatory cytokines IL-17A, IL-17F and IL-23.

Key concepts: Proinflammatory cytokine, Interleukin 17, Medicine, Immunology, Interleukin, Infliximab, Tumor necrosis factor alpha, Inflammation

Back to paper searchBrowse research topicsOriginal source
Динамика сывороточных il-17а, il-17f и IL-23 у больных воспалительными заболеваниями кишечника — Research Paper | ScholarLens